Heparin and the peritoneal membrane
Margetts, P.
Peritoneal Dialysis International Journal of the International Society for Peritoneal Dialysis 29(1): 16-19
2009
ISSN/ISBN: 0896-8608 PMID: 19164247 Document Number: 12877
Despite the additional insight provided by the Schilte study, the potential long-term benefits of heparin, especially LMWH, as a dialysate additive in PD patients remains to be elucidated.
Document emailed within 1 workday
Related Documents
Canavese, C.; Salomone, M.; Mangiarotti, G.; Pacitti, A.; Trucco, S.; Scaglia, C.; Assone, F.; Lunghi, F.; Vercellone, A. 1986: Heparin transfer across the rabbit peritoneal membrane Clinical Nephrology 26(3): 116-120Benaroia, M.; Morton, A.R.; Cheeseman, F.D.; Garland, J.S.; Toffelmire, E.B. 2008: Spontaneous peritoneal membrane rupture with extravasation of peritoneal fluid into the lower limbs and flank in a peritoneal dialysis patient Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 28(5): 554-557
Tiozzo, R.; Reggiani, D.; Croce, M.A.; Calandra, S.; Osima, B.; Bianchini, P. 1997: Effect of heparin on cell proliferation: lack of correlation with heparin binding sites on cell membrane Drugs under Experimental and Clinical Research 23(3-4): 103-109
Paríková, A. 2008: Ultrafiltration and prevention of alteration of peritoneal membrane--determinants of success of peritoneal dialysis therapy Vnitrni Lekarstvi 54(12): 1127-1128
Dai, H.-l.; Lin, A.-w.; Qian, J.-q.; Fang, W.; Ni, Z.-h.; Cao, L.-o.; Lin, X.-h.; Wu, Q.-w. 2010: Icodextrin improve angiogenesis of peritoneal membrane in continuous ambulatory peritoneal dialysis patients Zhonghua Yi Xue Za Zhi 90(40): 2843-2847
Aguilera, A.; Yáñez-Mo, M.; Selgas, R.; Sánchez-Madrid, F.; López-Cabrera, M. 2005: Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients Current Opinion in Investigational Drugs 6(3): 262-268
Jearnsujitwimol, V.; Eiam-Ong, S.; Kanjanabuch, T.; Wathanavaha, A.; Pansin, P. 2006: The effect of angiotensin Ii receptor blocker on peritoneal membrane transports in continuous ambulatory peritoneal dialysis patients Journal of the Medical Association of Thailand 89(Suppl 2): S188-S195
Krediet, R.T. 2001: Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 21(6): 560-567
Yamamoto, R.; Nakayama, M.; Hasegawa, T.; Miwako, N.; Yamamoto, H.; Yokoyami, K.; Ikeda, M.; Kato, N.; Hayakawa, H.; Takahashi, H.; Otsuka, Y.; Kawaguchi, Y.; Hosoya, T. 2002: High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 18: 131-134
Goel, S.; Misra, M.; Saran, R.; Khanna, R. 1998: The rationale for, and role of, heparin in peritoneal dialysis Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 14: 111-115
Yurt, R.W.; Leid, R.W.; Spragg, J.; Austen, K.F. 1977: Immunologic release of heparin from purified rat peritoneal mast cells Journal of Immunology 118(4): 1201-1207
Strong, D.K.; Ho, W.; Nairn, J.G. 1989: Visual compatibility of vancomycin and heparin in peritoneal dialysis solutions American Journal of Hospital Pharmacy 46(9): 1832-1833
Tatarkiewicz, K.; Sitarek, E.; Fiedor, P.; Sabat, M.; Orlowski, T. 1994: Protamine-heparin membrane for cell microencapsulation Transplantation Proceedings 26(6): 3509
Zareie, M.; Keuning, E.D.; ter Wee, P.M.; Beelen, R.H.J.; van den Born, J. 2004: Improvement of a chronic rat model for peritoneal dialysis by using heparin-coated catheters Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 20: 150-154
Umarova, B.A.; Khlgatian, S.V.; Strukova, S.M. 1989: Alpha-thrombin stimulation of heparin secretion by the peritoneal mast cells in rats Biulleten' Eksperimental'noi Biologii i Meditsiny 107(2): 131-133
De Vriese, A.S.; Mortier, S.; Cornelissen, M.; Palmans, E.; Vanacker, N.J.; Leyssens, A.; Faict, D.; De Ridder, L.; Lameire, N.H. 2002: The effects of heparin administration in an animal model of chronic peritoneal dialysate exposure Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 22(5): 566-572
Cherkas, D.D.; Skorik, V.I.; Novikova, S.P.; Shilov, V.V.; Kazakov, S.P. 1992: The gas-exchange properties of membrane blood oxygenators with immobilized heparin Anesteziologiia i Reanimatologiia 4: 56-57
White, M.M.; Siders, L.; Jennings, L.K.; White, F.L. 1992: The effect of residual heparin on the interpretation of heparin-induced platelet aggregation in the diagnosis of heparin-associated thrombocytopenia Thrombosis and Haemostasis 68(1): 88
Nikolic, L.B. 1998: Angiogenesis in rabbit cornea after disruption of descemet's membrane in the presence of heparin Vestnik Oftalmologii 114(4): 35-38
Sifil, A.; Mermut, C.; Yenicerioglu, Y.; Cavdar, C.; Gumustekin, M.; Celik, A.; Yuksel, F.; Camsari, T. 2003: Intraperitoneal and subcutaneous pharmacokinetics of low molecular weight heparin in continuous ambulatory peritoneal dialysis patients Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 19: 28-30